Most Popular

Dividend Stocks to Load Up for the Rest of Year: Apple Inc. (AAPL), Microsoft Corporation (MSFT), McDonald’s Corporation (MCD), Prospect Capital Corporation (PSEC)

Has the stock correction mostly run its course? Or are we in the early stages of a bear market?

Piper Jaffray Shines Light On Apple Inc. (AAPL) iPhone 6S Launch

Apple Inc. (NASDAQ:AAPL) fans have lined up at stores around the world to get the latest versions of the iPhone.

Synergy Pharmaceuticals Inc’s (SGYP) Plecanatide Still Big Opportunity: Canaccord

In a research report released this morning, Canaccord analyst Corey Davis reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with a …

BTIG Remains Bearish on Keryx Biopharmaceuticals (KERX) Despite Fexeric EU Approval; Reduces Price Target

BTIG analyst Hartaj Singh weighed in today with a pessimistic view on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company announced that its lead candidate Aurxyia (Fexeric in the …

Roth Capital Shines Light on Conatus Pharmaceuticals Inc (CNAT) Phase 2 Data for Emricasan

Roth Capital’s healthcare analyst Elemer Piros weighed in today with his views on Conatus Pharmaceuticals Inc (NASDAQ:CNAT), after the company announced positive data on the early …

Brean Capital Slashes Price Target for Keryx Biopharmaceuticals (KERX); Here’s Why

In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Keryx Biopharmaceuticals (NASDAQ:KERX), while reducing the …

Piper Jaffray Sets Expectations On Nike Inc Ahead Of F1Q:16 Results

In a research report released earlier today, Piper Jaffray analyst Erinn Murphy shared her expectations on Nike Inc (NYSE:NKE), as the company is scheduled to report its …

Pandora Media Inc (P) All-Time Royalties Surpass $1.5 Billion

Pandora Media Inc (NYSE:P), the leading Internet radio service, announced that it has generated more than $1.5 billion in all-time royalties for music …

Company Update (NYSE MKT:MSTX): Mast Therapeutics Inc to Host Analyst & Investor Day

Mast Therapeutics Inc (NYSEMKT:MSTX), a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts